secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astria Therapeutics, Inc. (—)
CIK:        0001454789
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001104659-24-030539
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astria Therapeutics enters $150M ATM equity offering agreement with Jefferies
-----------------------------------------------------------------------------

- Up to $150M of common stock may be sold through Jefferies as sales agent in at-the-market offerings.
- Jefferies receives up to 3.0% commission; company reimburses up to $75K legal expenses.
- Company has no obligation to sell shares; either party may terminate at any time.
- Shares offered pursuant to existing shelf registration statement on Form S-3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1454789/000110465924030539/0001104659-24-030539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1454789/000110465924030539/tm247711d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-030539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer